Volume | 158,542 |
|
|||||
News | - | ||||||
Day High | 3.51 | Low High |
|||||
Day Low | 3.36 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Myomo Inc | MYO | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.43 | 3.36 | 3.51 | 3.43 | 3.42 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
710 | 158,542 | US$ 3.45 | US$ 547,069 | - | 0.371 - 5.5799 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 476 | US$ 3.43 | USD |
Myomo Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
96.57M | 28.49M | - | 19.24M | -8.15M | -0.29 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Myomo News
Date | Time | Source | News Article |
---|---|---|---|
3/28/2024 | 15:05 | Business Wire | Myomo Appoints Heather Getz to its Board of Directors |
3/11/2024 | 07:05 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/11/2024 | 06:50 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/07/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
3/07/2024 | 15:05 | Business Wire | Myomo Reports Fourth Quarter and Full Year 2023 Financial.. |
3/06/2024 | 06:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
3/04/2024 | 18:12 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/01/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
3/01/2024 | 07:00 | Business Wire | CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the.. |
2/29/2024 | 15:05 | Business Wire | Myomo to Report Fourth Quarter Financial Results on March 7,.. |
2/22/2024 | 15:54 | Edgar (US Regulatory) | Form 8-K - Current report |
2/15/2024 | 09:42 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.85 | 3.64 | 2.85 | 3.35 | 155,692 | 0.58 | 20.35% |
1 Month | 3.16 | 3.64 | 2.5108 | 3.06 | 182,700 | 0.27 | 8.54% |
3 Months | 3.36 | 4.1899 | 2.5108 | 3.42 | 275,853 | 0.07 | 2.08% |
6 Months | 1.14 | 5.5799 | 1.06 | 3.66 | 486,405 | 2.29 | 200.88% |
1 Year | 0.5961 | 5.5799 | 0.371 | 2.38 | 439,575 | 2.83 | 475.41% |
3 Years | 10.00 | 14.35 | 0.369 | 1.93 | 334,335 | -6.57 | -65.70% |
5 Years | 1.18 | 40.00 | 0.26 | 3.72 | 363,790 | 2.25 | 190.68% |
Myomo Description
Myomo Inc is a medical robotics company. It develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. Myomo develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The company's products are referred to patients at leading rehabilitation facilities, including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Kennedy Krieger Institute, Loma Linda Medical Center and twenty VA hospitals, among others. |